Article Text

Download PDFPDF
EP998 Comparison of laparoscopy and laparotomy in the surgical management of early-stage ovarian cancer
  1. N Garcia Ginjaume,
  2. C Soler Moreno,
  3. N Teixeira,
  4. S Marin Garrayo,
  5. R Luna Guiborg and
  6. R Rovira Negre
  1. Gynaecology and Obstetrics, Hospital de la Santa Creu i Sant Pau de Barcelona, Barcelona, Spain


Introduction/Background We aimed to assess the feasibility and survival outcomes of laparoscopic surgical staging for patients with early-stage ovarian cancer compared with laparotomic approach.

Methodology Retrospective observational study which included forty-six patients who underwent laparoscopy (20 patients) or laparotomy (26 patients) for surgical staging of early-ovarian cancer between 2010 and 2018 were included. We analyzed clinical data and compared surgical and survival outcomes of both approaches.

Results Mean age was 60±20 years. Nineteen patients were classified as stage IA, 22 as stage IC, 2 as stage IIA and 3 as stage IIB. Histological types included: serous in 16, mucinous in 5, clear cell in 10 and endometrioid in 6 patients, 9 cases were classified as others, including carcinoid, yolk-sac, disgerminoma, granulosa-cell and seromucinous.

The laparoscopy group compared to the laparotomy group presented significantly shorter hospital stay (4,8 vs.9,2 days) and lower complication rate (2% vs. 22%).

In the laparotomy group 1 patient presented intraoperative vascular injury and another urologic injury. Postoperatively 2 patients presented respiratory infection, 3 urinary infection, 1 haemorrhage, 1 paralytic ileus and 1 asymptomatic lymfocele. In the laparoscopy group no patients presented intraoperative complications. Postoperatively, 1 patient presented symptomatic lymfocele.

Intraoperative blood loss tended to be lower in laparoscopy (197,1 vs 459,1 ml), although the difference was not statistically significant(p=0,07).

No significant differences were found in operative time, number of removed lymph nodes, intraoperative tumour rupture rate, postoperative chemotherapy, recurrence or survival rates.

Thirteen patients presented disease recurrence; 10 of which had undergone laparotomy.

Overall survival was 93%, with a median follow-up of 37 months.

Conclusion Laparoscopic staging performed by a trained gynaecologic-oncologist is a safe and effective alternative for early ovarian cancer. It has the advantage of minimum invasiveness, providing a shorter hospital stay and faster recovery, whilst preserving the requirements of an optimal surgery and the survival outcomes compared to laparotomic approach.

Disclosure Nothing to disclose.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.